Viviana Gatta

Ms. Viviana Gatta


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 September 2023 in Cellular and Molecular Neurobiology
Verified
Journal Article
Open access
PDF file
FBFloriana Burgio
Floriana Burgio
CGCarine Gaiser
Carine Gaiser
KBKevin Brady
Kevin Brady
VGViviana Gatta
Viviana Gatta
RCReiner Class
Reiner Class
LSLaura Suter-Dick
Laura Suter-Dick
Delivering biologics to elicit a therapeutic response in the central nervous system (CNS) remains challenging due to the presence of the blood–brain barrier (BBB). Receptor-mediated transcytosis is a strategy to improve brain exposure after systemic drug administration. The availability of a clinically relevant in vitro BBB model is crucial to investigate transcytosis pathways and to predict the penetration of biologics into the CNS. We created a perfused human in vitro BBB model made of induced pluripotent stem cells (iPSC)-derived brain microvascular endothelial cells (BMEC) for studying transferrin receptor-mediated transcytosis. iPSC-derived BMEC were seeded in the top channel of a three-lane microfluidic device (OrganoPlate®). After 2 days in culture, the established cell model exhibited relevant BBB features, including physiological transendothelial electrical resistance in a transwell setting (1500 Ω*cm2), reduced apparent permeability (Papp) to the fluorescence tracer Lucifer yellow (20-fold less than cell-free chips), expression of key BBB markers such as tight junctions proteins, transporters, receptors and functional P-gp efflux pump. Moreover, the model exhibited functional transferrin receptor-mediated uptake and transcytosis. To assess selective transferrin receptor-mediated transcytosis, a mixture of anti-human transferrin receptor (MEM-189) and control (sheep IgG anti-bovine serum albumin) antibodies was perfused in the top channel for 2 h. The Papp of MEM-189 was 11-fold higher than that of the control antibody, demonstrating facilitated receptor-mediated transcytosis. Compared to published work reporting a 2-fold ratio, this result is remarkable and establishes the suitability of our model for exploring receptor-mediated transcytosis and screening of antibodies for putative brain shuttle application. Graphical Abstract A perfused in vitro human model made of iPSC-derived BMEC with the chief characteristics (barrier tightness, functionality) of the human BBB can be applied to study transferrin receptor (TfR)-mediated transcytosis of therapeutic antibodies. This may bring critical advances in drug shuttle technology. Graphical abstract generated with biorender.com.

20 February 2019 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
SSSilvia Stotani
Silvia Stotani
VGViviana Gatta
Viviana Gatta
PMPrasanthi Medarametla
Prasanthi Medarametla
MPMohan Padmanaban
Mohan Padmanaban
AKAnna Karawajczyk
Anna Karawajczyk
Simona CollinaSimona Collina
Simona Collina

6 October 2018 in Molecules
Verified
Journal Article
Open access
PDF file
SSSilvia Stotani
Silvia Stotani
VGViviana Gatta
Viviana Gatta
FMFederico Medda
Federico Medda
MPMohan Padmanaban
Mohan Padmanaban
AKAnna Karawajczyk
Anna Karawajczyk
Simona CollinaSimona Collina
Simona Collina
Resistance to antibiotics is an increasingly serious threat to global public health and its management translates to significant health care costs. The validation of new Gram-negative antibacterial targets as sources for potential new antibiotics remains a challenge for all the scientists working in this field. The interference with bacterial Quorum Sensing (QS) mechanisms represents a potentially interesting approach to control bacterial growth and pursue the next generation of antimicrobials. In this context, our research is focused on the discovery of novel compounds structurally related to (S)-4,5-dihydroxy-2,3-pentanedione, commonly known as (S)-DPD, a small signaling molecule able to modulate bacterial QS in both Gram-negative and Gram-positive bacteria. In this study, a practical and versatile synthesis of racemic DPD is presented. Compared to previously reported syntheses, the proposed strategy is short and robust: it requires only one purification step and avoids the use of expensive or hazardous starting materials as well as the use of specific equipment. It is therefore well suited to the synthesis of derivatives for pharmaceutical research, as demonstrated by four series of novel DPD-related compounds described herein.

Verified
Journal Article
Open access
PDF file
VGViviana Gatta
Viviana Gatta
PIPolina Ilina
Polina Ilina
APAlison Porter
Alison Porter
SMStuart McElroy
Stuart McElroy
PTPäivi Tammela
Päivi Tammela
Since quorum sensing (QS) is linked to the establishment of bacterial infection, its inactivation represents one of the newest strategies to fight bacterial pathogens. LsrK is a kinase playing a key role in the processing of autoinducer-2 (AI-2), a quorum-sensing mediator in gut enteric bacteria. Inhibition of LsrK might thus impair the quorum-sensing cascade and consequently reduce bacterial pathogenicity. Aiming for the development of a target-based assay for the discovery of LsrK inhibitors, we evaluated different assay set-ups based on ATP detection and optimized an automation-compatible method for the high-throughput screening of chemical libraries. The assay was then used to perform the screening of a 2000-compound library, which provided 12 active compounds with an IC50 ≤ 10 µM confirming the effectiveness and sensitivity of our assay. Follow-up studies on the positive hits led to the identification of two compounds, harpagoside and rosolic acid, active in a cell-based AI-2 QS interference assay, which are at the moment the most promising candidates for the development of a new class of antivirulence agents based on LsrK inhibition.

30 October 2018 in ChemMedChem
Verified
Journal Article
Closed access
PDF file
PMPrasanthi Medarametla
Prasanthi Medarametla
VGViviana Gatta
Viviana Gatta
TKTommi Kajander
Tommi Kajander
TLTuomo Laitinen
Tuomo Laitinen
PTPäivi Tammela
Päivi Tammela
APAntti Poso
Antti Poso

6 February 2020 in ChemBioChem
Verified
Journal Article
Closed access
PDF file
VGViviana Gatta
Viviana Gatta
TTTihomir Tomašič
Tihomir Tomašič
JIJanez Ilaš
Janez Ilaš
NZNace Zidar
Nace Zidar
LMLucija Peterlin Mašič
Lucija Peterlin Mašič
PTPäivi Tammela
Päivi Tammela